Target hematologic values in the management of essential thrombocythemia and polycythemia vera

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-0609|94|1|4-11

ISSN： 0902-4441

Source： EUROPEAN JOURNAL OF HAEMATOLOGY, Vol.94, Iss.1, 2015-01, pp. : 4-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk‐stratification and management

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 2, 2015-02 ,pp. : 162-173

John Wiley & Sons Inc

Access to resources Recommend Favorite

Initial (Latent) Polycythemia vera with Thrombocytosis Mimicking Essential Thrombocythemia

By  

Acta Haematologica, Vol. 113, Iss. 4, 2005-06 ,pp. : 213-219

Karger

Access to resources Recommend Favorite

New and treatment‐relevant risk stratification for thrombosis in essential thrombocythemia and polycythemia vera

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 8, 2015-08 ,pp. : 683-685

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor and Thrombopoietin in Patients with Essential Thrombocythemia and Polycythemia vera and Thrombotic Complications

By  

Acta Haematologica, Vol. 110, Iss. 4, 2003-12 ,pp. : 202-203

Karger

Access to resources Recommend Favorite

Perspectives on the increased risk of second cancer in patients with essential thrombocythemia, polycythemia vera and myelofibrosis

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 2, 2015-02 ,pp. : 96-98

John Wiley & Sons Inc

Access to resources Recommend Favorite